The accumulation of MSCs within the tumor stroma is also supported by increasing cytokine concentrations of fibroblast growth factor-2, monocyte chemotactic protein-1 (=CCL2), CCL5, and stromal cell-derived factor 1 (=CXCL12). Here, CCL2 is linked to neoplasm.